Quadrant Capital Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.27M | Sell |
|
|||||
|
2025
Q1 | $2.59M | Buy |
|
|||||
|
2024
Q4 | $1.01M | Buy |
|
|||||
|
2024
Q3 | $1.16M | Buy |
|
|||||
|
2024
Q2 | $1.16M | Buy |
|
|||||
|
2024
Q1 | $981K | Buy |
|
|||||
|
2023
Q4 | $944K | Buy |
|
|||||
|
2023
Q3 | $781K | Sell |
|
|||||
|
2023
Q2 | $796K | Sell |
|
|||||
|
2023
Q1 | $738K | Buy |
|
|||||
|
2022
Q4 | $579K | Sell |
|
|||||
|
2022
Q3 | $583K | Buy |
|
|||||
|
2022
Q2 | $522K | Buy |
|
|||||
|
2022
Q1 | $397K | Buy |
|
|||||
|
2021
Q4 | $312K | Buy |
|
|||||
|
2021
Q3 | $216K | Sell |
|
|||||
|
2021
Q2 | $270K | Sell |
|
|||||
|
2021
Q1 | $312K | Buy |
|
|||||
|
2020
Q4 | $336K | Buy |
|
|||||
|
2020
Q3 | $344K | Buy |
|
|||||
|
2020
Q2 | $363K | Sell |
|
|||||
|
2020
Q1 | $594K | Buy |
|
|||||
|
2019
Q4 | $435K | Buy |
|
|||||
|
2019
Q3 | $305K | Buy |
|
|||||
|
2019
Q2 | $319K | Buy |
|
|||||
|
2019
Q1 | $270K | Buy |
|
|||||
|
2018
Q4 | $125K | Buy |
|
|||||
|
2018
Q3 | $122K | Buy |
|
|||||
|
2018
Q2 | $99K | Sell |
|
|||||
|
2018
Q1 | $100K | Buy |
|
|||||
|
2017
Q4 | $85K | Buy |
|
|||||
|
2017
Q3 | $87K | Buy |
|
|||||
|
2017
Q2 | $69K | Buy |
|
|||||
|
2017
Q1 | $51K | Buy |
|
|||||
|
2016
Q4 | $29K | Sell |
|
|||||
|
2016
Q3 | $39K | Buy |
|
|||||
|
2016
Q2 | $36K | Buy |
|
|||||
|
2016
Q1 | $31K | Sell |
|
|||||
|
2015
Q4 | $116K | Sell |
|
|||||
|
2015
Q3 | $99K | Buy |
|
|||||
|
2015
Q2 | $109K | Buy |
|